# Recursion Pharmaceuticals (stock symbol: RXRX) Logo in transparent PNG format

## Recursion Pharmaceuticals Logo large

### Recursion Pharmaceuticals Logo large Download PNG (58.96 KB)

![Recursion Pharmaceuticals Logo large Download PNG (58.96 KB)](/img/orig/RXRX_BIG-0b85b3ab.png)

## Recursion Pharmaceuticals Logo icon format

### Recursion Pharmaceuticals Logo icon format Download PNG (41.69 KB)

![Recursion Pharmaceuticals Logo icon format Download PNG (41.69 KB)](/img/orig/RXRX-ce4dd825.png)

## Recursion Pharmaceuticals Logo large for dark backgrounds

### Recursion Pharmaceuticals Logo large for dark backgrounds Download PNG (59.14 KB)

![Recursion Pharmaceuticals Logo large for dark backgrounds Download PNG (59.14 KB)](/img/orig/RXRX_BIG.D-fdbbea56.png)

## About Recursion Pharmaceuticals

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial adenomatous polyposis; and REC-3599, which is in Phase I clinical trial to treat GM2 gangliosidosis. Its preclinical stage product includes REC-3964 to treat Clostridium difficile colitis; REC-64917 for the treat of neural or systemic inflammation; REC-65029 to treat HRD-negative ovarian cancer; REC-648918 to enhance anti-tumor immune; REC-2029 for the treatment of wnt-mutant hepatocellular carcinoma; REC-14221 to treat solid and hematological malignancies; and REC-64151 for the treatment of immune checkpoint resistance in KRAS/STK11 mutant non-small cell lung cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

1. Website domain: recursion.com
2. Employees: 400
3. Marketcap: $0.91 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
